BENGALURU, June 1, 2017 /PRNewswire/ --
London & Partners, the official promotional agency of the Mayor of London, has declared RxPrism Health Systems among the 20 most innovative and high growth companies with global aspirations in India. The India Emerging 20 (IE20) award is adjudged using a robust rating scale by an esteemed panel of business leaders, venture capitalists and entrepreneurs.
(Photo: http://mma.prnewswire.com/media/517815/RxPrism_IE20_award.jpg )
(Logo:http://mma.prnewswire.com/media/456349/PRNE__RxPrism_Health_Systems_Pvt__Ltd_Logo.jpg )
Notable panel judges for the final round were Kiran Mazumdar-Shaw, the Chairperson and Managing Director of Biocon Limited; David Slater, the Director of International Trade and Investment of London & Partners; Mark Ling, the Head of International Large Corporates for Santander UK Corporate & Commercial; and Natarajan R , the Chief Operating Officer and CFO of RNT Capital Advisers, a venture fund launched by Tata Sons.
As an IE20 winner, RxPrism will have the unique opportunity to participate in key events at the London Tech Week in June 2017, interact with the who's who of the industry, foster global alliances and partnerships, and expand its footprints further.
Over the years, RxPrism has been featured among the 50 best companies to work for (as declared by Silicon Review), 25 fastest growing 3-D technology companies in India (The CEO Magazine), 20 most promising healthcare technology providers in India (CIO Review), best healthcare digital marketing company of 2016 (CIO Review), and so on.
Besides, RxPrism's creativity and digital innovation have also been hugely acknowledged and rewarded by numerous international forums, such as RxClub, MarCom, Hermes, Webby, and New York Festivals®. From among the pharma players, RxPrism was adjudged the winner of the Innovation Factory Contest held at Dubai on February 13, 2017, by MSD (Merck & Co.).
Dr Maruthi Viswanathan, the Founder and CEO of RxPrism, said, "This recognition validates our drive for high performance, innovation, differentiation, and global scalability. Awards like IE20 motivate us to surpass all expectations and unceasingly deliver the best in healthcare digital innovation."
For more information on the award, please click http://www.indiaemerging20.com/#winners-2017
About RxPrism RxPrism is a customer engagement specialist offering personalised digital solutions for pharma and life science companies to enhance the value and commercial success of their brands. Through several disruptive patent-pending technologies that integrate cloud, APPs, IoTs and 3-D virtualisation, RxPrism addresses the digital drift in healthcare by providing patients with access to any healthcare professionals or medical information worldwide. For more info, visit http://www.rxprism.com.
Media Contact: Arul Bala Sundaresan Head - Administration RxPrism Health Systems Pvt. Ltd. [email protected] +91-9886810792
London & Partners, the official promotional agency of the Mayor of London, has declared RxPrism Health Systems among the 20 most innovative and high growth companies with global aspirations in India. The India Emerging 20 (IE20) award is adjudged using a robust rating scale by an esteemed panel of business leaders, venture capitalists and entrepreneurs.
Advertisement
(Photo: http://mma.prnewswire.com/media/517815/RxPrism_IE20_award.jpg )
(Logo:http://mma.prnewswire.com/media/456349/PRNE__RxPrism_Health_Systems_Pvt__Ltd_Logo.jpg )
Advertisement
Notable panel judges for the final round were Kiran Mazumdar-Shaw, the Chairperson and Managing Director of Biocon Limited; David Slater, the Director of International Trade and Investment of London & Partners; Mark Ling, the Head of International Large Corporates for Santander UK Corporate & Commercial; and Natarajan R , the Chief Operating Officer and CFO of RNT Capital Advisers, a venture fund launched by Tata Sons.
As an IE20 winner, RxPrism will have the unique opportunity to participate in key events at the London Tech Week in June 2017, interact with the who's who of the industry, foster global alliances and partnerships, and expand its footprints further.
Over the years, RxPrism has been featured among the 50 best companies to work for (as declared by Silicon Review), 25 fastest growing 3-D technology companies in India (The CEO Magazine), 20 most promising healthcare technology providers in India (CIO Review), best healthcare digital marketing company of 2016 (CIO Review), and so on.
Besides, RxPrism's creativity and digital innovation have also been hugely acknowledged and rewarded by numerous international forums, such as RxClub, MarCom, Hermes, Webby, and New York Festivals®. From among the pharma players, RxPrism was adjudged the winner of the Innovation Factory Contest held at Dubai on February 13, 2017, by MSD (Merck & Co.).
Dr Maruthi Viswanathan, the Founder and CEO of RxPrism, said, "This recognition validates our drive for high performance, innovation, differentiation, and global scalability. Awards like IE20 motivate us to surpass all expectations and unceasingly deliver the best in healthcare digital innovation."
For more information on the award, please click http://www.indiaemerging20.com/#winners-2017
About RxPrism RxPrism is a customer engagement specialist offering personalised digital solutions for pharma and life science companies to enhance the value and commercial success of their brands. Through several disruptive patent-pending technologies that integrate cloud, APPs, IoTs and 3-D virtualisation, RxPrism addresses the digital drift in healthcare by providing patients with access to any healthcare professionals or medical information worldwide. For more info, visit http://www.rxprism.com.
Media Contact: Arul Bala Sundaresan Head - Administration RxPrism Health Systems Pvt. Ltd. [email protected] +91-9886810792
